Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
ARMISTICE CAPITAL, LLC (CIK 1601086) reported $8.17B across 323 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: SPY ($2.39B, 29.24%), IWM ($1.74B, 21.32%), CYTK ($232.7M, 2.85%), AGIO ($193.3M, 2.37%), MDGL ($154.6M, 1.89%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SPY | STATE STR SPDR S&P 500 ETF T | $2.39B | 29.24% | 3.2M | Added |
| 2 | IWM | ISHARES TR | $1.74B | 21.32% | 5.8M | Added |
| 3 | CYTK | CYTOKINETICS INC | $232.7M | 2.85% | 2.7M | Added |
| 4 | AGIO | AGIOS PHARMACEUTICALS INC | $193.3M | 2.37% | 5.2M | Trimmed |
| 5 | MDGL | MADRIGAL PHARMACEUTICALS INC | $154.6M | 1.89% | 288,000 | Added |
| 6 | PTCT | PTC THERAPEUTICS INC | $141.2M | 1.73% | 1.7M | Trimmed |
| 7 | SUPN | SUPERNUS PHARMACEUTICALS | $123.1M | 1.51% | 2.6M | Added |
| 8 | TVTX | TRAVERE THERAPEUTICS INC | $117.7M | 1.44% | 2.1M | Trimmed |
| 9 | IMVT | IMMUNOVANT INC | $113.1M | 1.38% | 2.9M | Trimmed |
| 10 | INCY | INCYTE CORP | $102.0M | 1.25% | 900,005 | Added |
| 11 | NBIX | NEUROCRINE BIOSCIENCES INC | $90.3M | 1.10% | 535,838 | Trimmed |
| 12 | UNH | UNITEDHEALTH GROUP INC | $76.1M | 0.93% | 183,000 | Added |
| 13 | MLYS | MINERALYS THERAPEUTICS INC | $74.9M | 0.92% | 2.8M | Added |
| 14 | FRPT | FRESHPET INC | $74.5M | 0.91% | 1.3M | Added |
| 15 | DYN | DYNE THERAPEUTICS INC | $68.6M | 0.84% | 3.1M | Trimmed |
| 16 | AMZN | AMAZON COM INC | $67.8M | 0.83% | 284,562 | Added |
| 17 | RIGL | RIGEL PHARMACEUTICALS INC | $65.4M | 0.80% | 1.7M | Added |
| 18 | TMO | THERMO FISHER SCIENTIFIC INC | $61.4M | 0.75% | 122,480 | Added |
| 19 | IRWD | IRONWOOD PHARMACEUTICALS INC | $58.7M | 0.72% | 13.9M | Trimmed |
| 20 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $56.9M | 0.70% | 1.6M | Trimmed |
| 21 | REGN | REGENERON PHARMACEUTICALS | $56.0M | 0.69% | 89,809 | Added |
| 22 | NKTR | NEKTAR THERAPEUTICS | $50.5M | 0.62% | 724,000 | Added |
| 23 | S | SENTINELONE INC | $47.6M | 0.58% | 2.8M | Trimmed |
| 24 | SNY | SANOFI SA | $45.4M | 0.56% | 1.1M | Added |
| 25 | IMCR | IMMUNOCORE HLDGS PLC | $45.3M | 0.55% | 1.4M | Added |
Source: SEC Form 13F filings · as of 2026-06-30